BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31429161)

  • 41. Curcumin in epilepsy disorders.
    Dhir A
    Phytother Res; 2018 Oct; 32(10):1865-1875. PubMed ID: 29917276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome.
    Pérez-Torres I; Ruiz-Ramírez A; Baños G; El-Hafidi M
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):25-37. PubMed ID: 22721439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondria as a target in the therapeutic properties of curcumin.
    Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrí J
    Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protective effect of fermented Curcuma longa L. on memory dysfunction in oxidative stress-induced C6 gliomal cells, proinflammatory-activated BV2 microglial cells, and scopolamine-induced amnesia model in mice.
    Eun CS; Lim JS; Lee J; Lee SP; Yang SA
    BMC Complement Altern Med; 2017 Jul; 17(1):367. PubMed ID: 28716085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive systematic review of the therapeutic effects and mechanisms of action of quercetin in sepsis.
    Karimi A; Naeini F; Asghari Azar V; Hasanzadeh M; Ostadrahimi A; Niazkar HR; Mobasseri M; Tutunchi H
    Phytomedicine; 2021 Jun; 86():153567. PubMed ID: 33940332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dermatological effects of Curcuma species: a systematic review.
    Barbalho SM; de Sousa Gonzaga HF; de Souza GA; de Alvares Goulart R; de Sousa Gonzaga ML; de Alvarez Rezende B
    Clin Exp Dermatol; 2021 Jul; 46(5):825-833. PubMed ID: 33522006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin.
    Kuszewski JC; Wong RHX; Howe PRC
    Adv Nutr; 2018 Mar; 9(2):105-113. PubMed ID: 29659685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The action of curcumin against damage resulting from cerebral stroke: A systematic review.
    Marques MS; Marinho MAG; Vian CO; Horn AP
    Pharmacol Res; 2022 Sep; 183():106369. PubMed ID: 35914679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of therapeutic effects of curcumin.
    Noorafshan A; Ashkani-Esfahani S
    Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets.
    Ghanaatian N; Lashgari NA; Abdolghaffari AH; Rajaee SM; Panahi Y; Barreto GE; Butler AE; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12237-12248. PubMed ID: 30536381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Comprehensive Review on Physiological Effects of Curcumin.
    Ahsan R; Arshad M; Khushtar M; Ahmad MA; Muazzam M; Akhter MS; Gupta G; Muzahid M
    Drug Res (Stuttg); 2020 Oct; 70(10):441-447. PubMed ID: 32746480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-
    Kalani H; Shakib P; Faridnia R; Ho J; Mardanshah O; Dolatshah M; Sepahvand A; Cheraghipour K; Zivdaria M
    Infect Disord Drug Targets; 2023; 23(2):e200822207821. PubMed ID: 35996237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effect of tetrahydrocurcumin against cisplatin-induced renal damage: in vitro and in vivo studies.
    Song KI; Park JY; Lee S; Lee D; Jang HJ; Kim SN; Ko H; Kim HY; Lee JW; Hwang GS; Kang KS; Yamabe N
    Planta Med; 2015 Mar; 81(4):286-91. PubMed ID: 25719941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Promising Therapeutic Avenues of Curcumin in Brain Diseases.
    Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin and its analogues: a potential natural compound against HIV infection and AIDS.
    Prasad S; Tyagi AK
    Food Funct; 2015 Nov; 6(11):3412-9. PubMed ID: 26404185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition.
    Oh SW; Cha JY; Jung JE; Chang BC; Kwon HJ; Lee BR; Kim DY
    J Ethnopharmacol; 2011 Jul; 136(3):414-21. PubMed ID: 20643202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Curcumin on Immune Response: An Immunomodulatory Strategy to Treat Sepsis.
    Allegra A; Mirabile G; Ettari R; Pioggia G; Gangemi S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of curcumin on HDL functionality.
    Ganjali S; Blesso CN; Banach M; Pirro M; Majeed M; Sahebkar A
    Pharmacol Res; 2017 May; 119():208-218. PubMed ID: 28192240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.